Healthcare - Sector
Ocuphire Pharma's activity chart (see below) currently has 14 price targets and 25 ratings on display.
Analysts' price targets on this stock were met 10% of the time, taking 0.2 days on average.
Most recent stock forecast was given by JOHN NEWMAN from CANACCORD on 23-Oct-2024. First documented stock forecast 19-Nov-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Feb-2021
$10
2 years 30 days ago
(23-Oct-2024)
0/3 (0%)
$8.83 (754.70%)
Buy Since 24-Nov-2021
2 years 3 months 8 days ago
(14-Aug-2024)
0/2 (0%)
$15.84 (380.77%)
Buy Since 05-Apr-2021
$2.03
2 years 8 months 2 days ago
(20-Mar-2024)
1/2 (50%)
$-0.01 (-0.49%)
1
Buy Since 19-Nov-2020
$17
$22
3 years 3 months 8 days ago
(14-Aug-2023)
0/4 (0%)
$12.84 (308.65%)
Buy Since 29-Mar-2021
$20
$20
5 years 5 months 21 days ago
(01-Jun-2021)
0/2 (0%)
$15.21 (317.54%)
Which analyst most recently updated their price target on OCUP (Ocuphire Pharma)?
Which analyst has the lowest performance score on OCUP (Ocuphire Pharma) with a proven track record?
Which analyst has the most public recommendations on OCUP (Ocuphire Pharma)?
Which analyst is the currently most bullish on OCUP (Ocuphire Pharma)?
Which analyst is the currently most reserved on OCUP (Ocuphire Pharma)?